RT @bavilima: Cyclophosphamide for mCRPC when limited resources @CSuartz 👏👏👏 ✨33.4% of patients had PSA decline ✨13.2% achieved a PSA50 re…

@bavilima @ASCO @MikeSerzanMD @ReneeSaliby @yekeduz_emre @ReginaBarCar @crisbergerot @drenriquegrande @DRBakaloudiMD @OncoAlert @OncoReporte Kudos @bavilima 👏🏼👏🏼

@NOSMUUrology @thenosm @TBRHSC_NWO @ShahrourWalid @waleedshabana @DrPianezza @CanUrolAssoc @CaRMS_CA Congratulations to all aplicants

RT @NOSMUUrology: Thanks to our residents for the dedicated work and commitment @thenosm @TBRHSC_NWO @ShahrourWalid @waleedshabana @DrPiane…

RT @NOSMUUrology: Congratulations to all CARMS candidates. Looking forward to who will join NOSMU Urology @thenosm @TBRHSC_NWO @ShahrourWa…

@NOSMUUrology @thenosm @TBRHSC_NWO @ShahrourWalid @waleedshabana @DrPianezza Good luck to all applicants! I look forward to working with the selected candidates and starting our robotic surgery training program for residents!

@ResidentesCAU @CAU_URO

@GUOncologyNow @oncodaily @urotoday @OncoAlert @NCCN @NCICCR_UroOnc

@fkorkes @ptorenmd @ReisLO @Urologia_USP

RT @motajmsc: Oral cyclophosphamide is a feasible option for heavily pretreated patients with mCRPC. In this retrospective cohort of 341 pa…

RT @NOSMUUrology: NOSM U Urology features in newspaper @thenosm @TBRHSC_NWO @TBRHSF @ShahrourWalid @waleedshabana @DrPianezza @CSuartz htt…

RT @CSuartz: Inguinal Lymphadenectomy for Penile Cancer: Open or Laparoscopic? We compared only prospective studies in this meta-analysis p…

@GUOncologyNow @urotoday @OncoAlert @OncoDailyIO @oncodaily @SBOC_Oncologia

RT @CSuartz: Health care systems are heterogeneous, and in systems with limited resources, it is crucial to optimize therapy by offering th…

@Urologia_USP

@LauraBukavinaMD @CleClinicUro @UrologyMatch Thank you , Laura

@urotoday